Abstract: A method of retrofitting a steering knuckle of an amphibious vehicle to make the knuckle and axle assembly water-tight includes the steps of providing a neoprene rubber boot; attaching a flange to an axle of the vehicle; clamping one end of the boot to the flange; clamping the other end of the boot to the steering knuckle; and attaching a steering stop to either the axle or the flange.

Abstract: Briefly described, embodiments of this disclosure include compositions, pharmaceutical compositions, methods of treating a host infected with a virus from the Flaviviridae family of viruses, methods of treating HCV replication in a host, methods of inhibiting the binding of NS4B polypeptide to the 3?UTR of HCV negative strand RNA in a host, methods of treating liver fibrosis in a host, and the like.

Abstract: Briefly described, embodiments of this disclosure include compositions, pharmaceutical compositions, methods of treating a host infected with a virus from the Flaviviridae family of viruses, methods of identifying a candidate agent for the treatment of hepatitis C virus (HCV) infection, and the like.

Abstract: A boot for covering a steering knuckle of an amphibious vehicle comprising a flexible tube having a first end and a second end, wherein the first end comprises a molded groove for seating a first clamp, and wherein the second end comprises a straight cuff for clamping with a second clamp onto a flange of the steering mechanism of the amphibious vehicle.

Abstract: A boot for covering a steering knuckle of an amphibious vehicle comprising a flexible tube having a first end and a second end, wherein the first end comprises a molded groove for seating a first clamp, and wherein the second end comprises a straight cuff for clamping with a second clamp onto a flange of the steering mechanism of the amphibious vehicle.

Abstract: A method for preparing a catalyst that involves continuously supplying a first stream containing a solvent, one or more metal precursors, and one or more support materials, and a second stream containing at least one reducing agent and/or precipitating agent. The first and second streams are combined to form a combined stream. In one embodiment, the combined stream may be fed to a mixing vessel. In another embodiment, the streams are combined in a mixing vessel. After the streams are combined, one or more metal precursors is reduced or precipitated within the pores of the one or more support materials. Thereafter, solids are separated from the combined stream and processed to produce the supported metal, mixed-metal, metal oxide, or mixed-metal oxide catalyst. In another embodiment, ceramic or metallic monoliths may be coated with the catalytic material after the stream combination and before or after the solid separation and subsequent processing.

Abstract: Briefly described, embodiments of this disclosure include compounds, pharmaceutical compositions, methods of treating a host infected with a virus from the Flaviviridae family of viruses, methods of inhibiting HCV replication in a host, methods of inhibiting the binding of NS4B polypeptide to the 3?UTR of HCV negative strand RNA in a host, methods of treating liver fibrosis in a host, and the like.

Abstract: Briefly described, embodiments of this disclosure include compounds, pharmaceutical compositions, methods of treating a host infected with a virus from the Flaviviridae family of viruses, methods of inhibiting HCV replication in a host, methods of inhibiting the binding of NS4B polypeptide to the 3?UTR of HCV negative strand RNA in a host, methods of treating liver fibrosis in a host, and the like.

Abstract: A water-tight compartment for containing a penetration point on the hull of an amphibious vehicle, comprising a bottom panel comprising the hull of the amphibious vehicle; a forward panel of the box comprising a forward bulkhead of the amphibious vehicle; a rearward panel of the box comprising a rearward bulkhead of the amphibious vehicle; two lateral panels; and a top panel; wherein the panels are joined together in a water-tight manner and wherein there is a water-tight penetration point for a drive shaft in at least one of the panels.

Abstract: There are described cycloalkyl derivatives of the formula (I) R1—Y-A-B-D-E-F-G??(I) in which R1, Y, A, B, D, E, F and G have the meaning indicated herein, their preparation and their use as medicaments. The compounds according to the invention can be used as vitronectin receptor antagonists and as inhibitors of bone resorption.

Abstract: A boot for covering a steering knuckle of an amphibious vehicle comprising a flexible tube having a first end and a second end, wherein the first end comprises a molded groove for seating a first clamp, and wherein the second end comprises a straight cuff for clamping with a second clamp onto a flange of the steering mechanism of the amphibious vehicle.

Abstract: A water-tight compartment for containing a penetration point on the hull of an amphibious vehicle, comprising a bottom panel comprising the hull of the amphibious vehicle; a forward panel of the box comprising a forward bulkhead of the amphibious vehicle; a rearward panel of the box comprising a rearward bulkhead of the amphibious vehicle; two lateral panels; and a top panel; wherein the panels are joined together in a water-tight manner and wherein there is a water-tight penetration point for a drive shaft in at least one of the panels.

Abstract: There are described cycloalkyl derivatives of the formula (I) R1—Y-A-B-D-E-F-G ??(I) in which R1, Y, A, B, D, E, F and G have the meaning indicated herein, their preparation and their use as medicaments. The compounds according to the invention can be used as vitronectin receptor antagonists and as inhibitors of bone resorption.

Abstract: The present invention relates to acylguanidino derivatives of formula (I), in which R1, R2, R3, A, B, X, Y and n have the meanings indicated in claim 1, their physiologically tolerable salts and their prodrugs. The compounds of the formula (I) are valuable pharmaceutically active compounds. They are vitronectin receptor antagonists and inhibitors of cell adhesion and bone resorption by osteoclasts. This renders them suitable, for example, for the therapy and prophylaxis of illness which are based on the interaction between vitronectin receptors and their ligands in cell-cell or cell-matrix interaction processes or which can be prevented, alleviated or cured by influencing such interactions. For example, they can be applied for treating and preventing osteoporosis, or for inhibiting undesired angiogenesis or proliferation of cells of the vascular smooth muscles.

Abstract: The present invention comprises growth hormone releasing peptides/peptidomimetics (GHRP) capable of causing release of growth hormone from the pituitary. Compositions containing the GHRP's of this invention are used to promote growth in mammals either alone or in combination with other growth promoting compounds, especially IGF-1. In a method of this invention GHRP's in combination with IGF-1 are used to treat Type II diabetes. An exemplary compound of this invention is provided below.

Abstract: Compounds of the general structure D-L-B-(AA), for example (A), that are useful for treating Mac-1 or LFA-1-mediated disorders such as inflammatory disorders, allergies, and autoimmune diseases are provided.

Abstract: The invention concerns a method for rapid identification and characterization of binding partners for a target molecule, and for providing binding partners with improved binding affinity. More specifically, the invention concerns an improved tethering method for the rapid identification of at least two binding partners that bind near one another to a target molecule.

Abstract: The invention concerns a method for rapid identification and characterization of binding partners for a target molecule, and for providing binding partners with improved binding affinity. More specifically, the invention concerns an improved tethering method for the rapid identification of at least two binding partners that bind near one another to a target molecule.

Abstract: The present invention relates to compounds of the formula I A—B—D—E—F—G??(I) in which A, B, D, E, F and G have the meanings given in the patent claims, to their preparation and to their use as medicaments. The compounds of the invention are used as vitronectin receptor antagonists and as inhibitors of bone resorption.

Abstract: (2S)-2-(Adamantan-1-ylmethoxycarbonylamino)-3-(4-(2-(1,4,5,6-tetrahydropyrimidin-2-ylcarbamoyl)ethyl)benzoylamino)propionic acid isopropyl ester, its preparation and its use The present invention relates to (2S)-2-(adamantan-1-ylmethoxycarbonylamino)-3-(4-(2-(1,4,5,6-tetrahydropyrimidin-2-ylcarbamoyl)ethyl)benzoylamino)propionic acid isopropyl ester of the formula I and its physiologically tolerable salts, their preparation, their use as pharmaceuticals and to pharmaceutical compositions comprising them. The compound of the formula I and its physiologically tolerable salts are valuable pharmacologically active compounds which can be used, for example, in the treatment or prophylaxis of diseases which can be influenced by inhibiting the vitronectin receptor, for example of bone diseases such as osteoporosis.